MG Granules Improve COVID-19 Efficacy and Safety of Convalescent Exercise Tolerance Read more about MG Granules Improve COVID-19 Efficacy and Safety of Convalescent Exercise Tolerance
Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine Read more about Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine
The Canadian Respiratory Research Network Long COVID-19 Study Read more about The Canadian Respiratory Research Network Long COVID-19 Study
COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics Read more about COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics
TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19 Read more about TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19
Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above Read more about Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above
Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 Read more about Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years Read more about Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years
Antihistamines, Amantadine and Evolution of the SARS-CoV-2 Infection Read more about Antihistamines, Amantadine and Evolution of the SARS-CoV-2 Infection
Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses) Read more about Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)
